Cite

    Lea Tschaidse et al.. “Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia.” European journal of endocrinology, vol. 188, no. 1, 2023, p. . http://access.bl.uk/ark:/81055/vdc_100179866793.0x000024